ANITA THOMPKINS: Open Payments
NPI 1619324829 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 24 payments from 13 companies in 2025. Trend: 2023 $907 · 2024 $1,666 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $169 |
| Abbott Laboratories | 1 | $145 |
| E.R. Squibb & Sons, L.L.C. | 3 | $141 |
| SCPHARMACEUTICALS INC. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $121 |
| BIOTRONIK INC. | 2 | $111 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Kestra Medical Technology Services, Inc. | 1 | $38 |
| Alnylam Pharmaceuticals Inc. | 1 | $34 |
Products named: REPATHA, CARDIOMEMS, CAMZYOS, FUROSCIX, JARDIANCE, AMVIA EDGE, LEQVIO, Acticor 7 VR-T DX.
Industry payments across TX — which companies pay providers there.
